FOXP3 overexpression in mature CD8 T cells improves their antitumor efficacy in adoptive T cell therapy, favoring their metabolic adaptation to the tumor microenvironment as well as their recruitment, proliferation, and cytotoxicity within tumors. This evidence concerns the gene CD8A and neoplasm.